Prepared by the editors of Harvard Health Publishing in consultation with Chika V
With the development of genetic testing technologies such as genome-wide association studies (GWAS) and next-generation sequencing (NGS), it has been discovered that approximately 127 locus abnormalities in the human genome are associated with the onset and progression of obesity [4] , as along with more than 550 monogenic mutations related to obesity [5]
That is why protein intake, strength training, and proper coaching are important parts of a well-rounded plan
Today, studies estimate that over 80 percent of the personalized compounded GLP-1 drugs now being marketed include added ingredients such as B vitamins (B6, B12, B3)
Furthermore, GLP-1 decreases gastrointestinal motility extending the entry of nutrients to be absorbed by the GIT [18]
What I want patients to understand is that this is not an argument against GLP-1 treatment